Is the pharma market, which is currently at INR2.17 lakh crore (USD25.8 billion), getting too crowded? While some industry experts believe a few clear signs of fatigue have emerged, many say it is not a doom scenario yet and a rebound may not be far.
Related Posts
Why New Delhi needs to mount an India-driven global health-diplomacy push, and what it needs to do
Workers unload cartons of a Covid-19 coronavirus vaccine being delivered from India to Myanmar Synopsis The pandemic has catapulted India…
This Ranjan Pai investment opens the door to a USD30 billion opportunity
Ranjan Pai is among India’s most influential investors. So, when he makes a move into senior care, it is time…
What’s making GBS nerve disorder go viral in Pune
Getty Images Guillain-Barre syndrome (GBS) test, a rare disorder where the body’s immune system damages nerve Synopsis Guillain-Barré Syndrome is…
